Extraction and purification of serum specific endothelial cell antibody of renal transplant recipients
-
摘要:
目的 探讨肾移植术后出现排斥反应的受者血清中抗血管内皮细胞特异性抗体的提取和纯化方法。 方法 首先分离培养人脐静脉血管内皮细胞(HUVEC)。收集肾移植术后肾功能不良受者的血清样本, 应用流式细胞术进行抗血管内皮细胞特异性抗体的筛选; 用Luminex抗体检测平台检测血清中抗人类白细胞抗原(HLA)和主要组织相容性复合体Ⅰ类相关链A (MICA)的抗体。在确定血清标本中存在有抗血管内皮细胞特异性抗体后, 用HUVEC将其吸附。洗涤细胞后再将吸附的抗体从细胞膜上洗脱下来, 再用Protein-A/G磁珠再次纯化和浓缩洗脱液中的抗体IgG。采用流式细胞术检测洗脱液中抗体活性, 用SDS-聚丙烯酰胺凝胶(SDS-PAGE)凝胶和免疫印迹法鉴定纯化的抗血管内皮细胞特异性抗体(IgG)。 结果 在386例肾移植受者的血清中, 选取血清肌酐(Scr)>400 μmoI/L、抗HLA抗体阴性、抗MICA抗体阴性和荧光反应强度(MFI)>16的5例受者的血清样本, 纯化后的抗血管内皮细胞特异性抗体IgG在SDS-PAGE凝胶显示免疫球蛋白重链(纯度>95%)。流式细胞术结果显示纯化的抗体具有重新结合血管内皮细胞表面抗原的特性。 结论 采用人脐静脉血管内皮细胞吸附肾移植受者血清中抗血管内皮细胞特异性抗体的提纯方法可取得较好效果。 -
关键词:
- 肾移植 /
- 免疫排斥反应 /
- 抗血管内皮细胞特异性抗体 /
- 抗体吸附 /
- 人血管内皮细胞
Abstract:Objective To investigate the extraction and purification methods of serum specific endothelial cell antibody of renal transplant recipients with rejection after renal transplantation. Methods Human umbilical vein endothelial cell (HUVEC) was isolated and cultured. The serum samples of the renal transplant recipients with poor renal function after renal transplantation were collected. Specific endothelial cell antibody was screened out with flow cytometry; antibodies against human leukocyte antigen (HLA) and major histocompatibility complex class Ⅰ-related chain A (MICA) were detected by Luminex platform. After the existence of specific endothelial cell antibody in the serum sample was confirmed, specific endothelial cell antibody was absorbed with HUVEC. The cell was washed and then the absorbed antibody was eluted from the cell membrane. Antibody IgG in the eluent was purified and concentrated again with Protein-A/G magnetic beads. Antibody activity in the eluent was detected by flow cytometry and the purified specific endothelial cell antibody (IgG) was identified by SDS-polyacrylamide gel (SDS-PAGE) and Western blot. Results In the serum of 386 renal transplant recipients, the serum samples of 5 renal transplant recipients with serum creatinine (Scr) >400 μmoI/L, negative anti-HLA antibody, negative anti-MICA antibody and median fluorescence intensity (MFI) >16 were selected. Purified specific endothelial cell antibody IgG showed immunoglobulin heavy chain (purity >95%) by SDS-PAGE gel. Flow cytometry showed that the purified antibody had the feature of rebinding with the surface antigen of vascular endothelial cell. Conclusions The purification method of using human umbilical vein endothelial cell to absorb specific endothelial cell antibody in the serum of renal transplant recipients may obtain good effect. -
图 1 显微镜下观察原代脐静脉内皮细胞的形态(×200)
Figure 1. Cell morphology of human umbilical cord vein endothelial cells under microscope
图 2 传代培养第6代人脐静脉内皮细胞的CD31表达
Figure 2. Expression of CD31 of human umbilical cord vein endothelial cells of 6th generation by subculture
图 3 1例肾移植受者血清与分离培养的不同个体的HUEVC的细胞流式反应结果示意图
Figure 3. Schematic diagram of flow cytometry results of serum of a renal transplant patient reacted with HUEVC from different donors
图 4 肾移植受者血清抗体与脐血T细胞和HUVEC的反应
注：红色峰为阴性对照；绿色峰为阳性对照；黑色峰为血清抗体
Figure 4. Reaction of serum antibodies of renal transplant recipient reacted with human umbilical cord vein endothelial cells and cord blood T cells
图 5 血清中抗血管内皮细胞特异性抗体吸收洗脱和活性恢复的过程
Figure 5. The process of absorption, elution and activity recovery of serum specific endothelial cell antibodies
-
[1] Lee PC, Terasaki PI, Takemoto SK, et al. All chronic rejection failures of kidney transplants were preceded by the development of HLA antibodies[J]. Transplantation, 2002, 74(8):1192-1194. doi: 10.1097/00007890-200210270-00025 [2] Worthington JE, Martin S, Dyer PA, et al. An association between posttransplant antibody production and renal transplant rejection[J]. Transplant Proc, 2001, 33(1/2):475-476. http://cat.inist.fr/?aModele=afficheN&cpsidt=1046596 [3] Zou Y, Heinemann FM, Grosse-Wilde H, et al. Detection of anti-MICA antibodies in patients awaiting kidney transplantation, during the post-transplant course, and in eluates from rejected kidney allografts by Luminex flow cytometry[J]. Hum Immunol, 2006, 67(3):230-237. doi: 10.1016/j.humimm.2006.02.017 [4] Zou Y, Stastny P, Susal C, et al. Antibodies against MICA antigens and kidney-transplant rejection[J]. N Engl J Med, 2007, 357(13):1293-1300. doi: 10.1056/NEJMoa067160 [5] Canet E, Devalliere J, Gerard N, et al. Profiling posttransplant circulating antibodies in kidney transplantation using donor endothelial cells[J]. Transplantation, 2012, 93(3):257-264. doi: 10.1097/TP.0b013e31823ec0ec [6] Jackson AM, Lucas DP, Melancon JK, et al. Clinical relevance and IgG subclass determination of non-HLA antibodies identified using endothelial cell precursors isolated from donor blood[J]. Transplantation, 2011, 92(1):54-60. doi: 10.1097/TP.0b013e31821b60e9 [7] Murata K, Baldwin WM 3rd. Mechanisms of complement activation, C4d deposition, and their contribution to the pathogenesis of antibody-mediated rejection[J]. Transplant Rev, 2009, 23(3):139-150. doi: 10.1016/j.trre.2009.02.005 [8] Sun Q, Cheng Z, Cheng D, et al. De novo development of circulating anti-endothelial cell antibodies rather than pre-existing antibodies is associated with post-transplant allograft rejection[J]. Kidney Int, 2011, 79(6):655-662. doi: 10.1038/ki.2010.437 [9] Zou Y, Qin Z, Silveus A, et al. Polymorphisms of MICA recognized by human alloantibodies[J]. Immunogenetics, 2009, 61(2):91-100. doi: 10.1007/s00251-008-0344-9 [10] Lechler RI, Sykes M, Thomson AW, et al. Organ transplantation:how much of the promise has been realized?[J]. Nat Med, 2005, 11(6):605-613. doi: 10.1038/nm1251 [11] Racusen LC, Colvin RB, Solez K, et al. Antibody-mediated rejection criteria-an addition to the Banff 97 classification of renal allograft rejection[J]. Am J Transplant, 2003, 3(6):708-714. doi: 10.1034/j.1600-6143.2003.00072.x [12] Nankivell BJ, Alexander SI. Rejection of the kidney allograft[J]. N Engl J Med, 2010, 363(15):1451-1462. doi: 10.1056/NEJMra0902927 [13] Flint SM, Walker RG, Hogan C, et al. Successful ABO-incompatible kidney transplantation with antibody removal and standard immunosuppression[J]. Am J Transplant, 2011, 11(5):1016-1024. doi: 10.1111/j.1600-6143.2011.03464.x [14] Zhang Q, Cecka JM, Gjertson DW, et al. HLA and MICA:targets of antibody-mediated rejection in heart transplantation[J]. Transplantation, 2011, 91(10):1153-1158. doi: 10.1097/TP.0b013e3182157d60 [15] Canet E, Devalliere J, Gerard N, et al. Profiling posttransplant circulating antibodies in kidney transplantation using donor endothelial cells[J]. Transplantation, 2012, 93(3):257-264. doi: 10.1097/TP.0b013e31823ec0ec [16] Jackson AM, Lucas DP, Melancon JK, et al. Clinical relevance and IgG subclass determination of non-HLA antibodies identified using endothelial cell precursors isolated from donor blood[J]. Transplantation, 2011, 92(1):54-60. doi: 10.1097/TP.0b013e31821b60e9 [17] Grafft CA, Cornell LD, Gloor JM, et al. Antibody-mediated rejection following transplantation from an HLA-identical sibling[J]. Nephrol Dial Transplant, 2010, 25(1):307-310. doi: 10.1093/ndt/gfp526 -
下载:
点击查看大图
图(6)
计量
- 文章访问数: 107
- HTML全文浏览量: 64
- PDF下载量: 5
- 被引次数: 0
